Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(17/week)
Canada
(12/week)
Haiti
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
View all
(29/week)
News
United States
(1301/week)
Manufacturing
(724/week)
Energy
(519/week)
Technology
(1265/week)
Other Manufacturing
(494/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Marker Therapeutics, Inc.
Jan 05, 2021
Marker Therapeutics Announces FDA Lifted Partial Clinical Hold on Phase 2 AML Clinical Trial
Aug 10, 2020
Marker Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Jun 30, 2020
Marker Therapeutics Announces New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T Cell Therapy Product Candidates
Jun 23, 2020
Marker Therapeutics Receives USAN Approval for "zelenoleucel" as Nonproprietary Name for MT-401, Multi-Tumor-Associated Antigen Targeted T Cell Product for Acute Myeloid Leukemia
May 29, 2020
Marker Therapeutics Reports Interim Results of its MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
May 04, 2020
Marker Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast on Monday, May 11, 2020
Apr 29, 2020
Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia
Mar 12, 2020
Marker Therapeutics Reports Full Year 2019 Operating and Financial Results
Mar 02, 2020
Marker Therapeutics and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $30 million
Feb 11, 2020
Marker Therapeutics Announces Update to its Clinical Program in AML
Nov 25, 2019
Marker Therapeutics to Present at Two Upcoming Investor Conferences
Nov 12, 2019
Marker Therapeutics Reports Third Quarter 2019 Operating and Financial Results
Nov 11, 2019
Marker Therapeutics to Host Third Quarter 2019 Operating and Financial Results Conference Call and Webcast on Tuesday, November 12, 2019
Aug 15, 2019
Marker Therapeutics Appoints Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs
Aug 08, 2019
Marker Therapeutics Reports Second Quarter 2019 Operating and Financial Results
Aug 06, 2019
Marker Therapeutics Appoints Steve Elms to its Board of Directors
Jul 20, 2019
Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR
Jul 17, 2019
Marker Therapeutics to Host Conference Call and Webcast to Review Interim Results from Phase 1/2 Clinical Trial with its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma
Jun 20, 2019
Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma
May 21, 2019
Marker Therapeutics to Present at Two Upcoming Investor Conferences
Page 1
››
Latest News
Jul 27, 2024
LuxCreo Expands Partnership with ASICS to Make Personalized Shoes Accessible to Everyone
Jul 27, 2024
Smith Foundry Shutting Down Minnesota Facility
Jul 27, 2024
Fonon Corporation Quartz Laser Welding Benefits Glass Manufacturers
Jul 27, 2024
Pioneer Power Announces Filing of Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023
Jul 27, 2024
Alliance Resource Partners, L.P. Declares Quarterly Distribution of $0.70 Per Unit; Announces Robinson...
Jul 27, 2024
EnerSys Completes Acquisition Of Bren-Tronics To Expand Presence In Critical Defense Applications
Jul 27, 2024
Warrior Announces Regular Quarterly Cash Dividend
Jul 27, 2024
ComEd Joins YMCA and Goodwill to Graduate 89 Local Teens from Summer Job Training Program
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
View All Events